ArriVent BioPharma (AVBP) Stock Chart & Stock Price History $18.46 +0.81 (+4.58%) As of 01:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ArriVent BioPharma Stock Price Performance The ArriVent BioPharma (AVBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 25.60%, with a year-to-date return of -30.71%. In the past month, the stock has decreased 8.21%, reflecting recent market activity. As of the latest close, ArriVent BioPharma traded at $17.65 with a market cap of $716.06 million and volume of 1.52 million shares. Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+5.42%1 Month Performance-8.21%3 Month Performance-26.81%Year-To-Date Performance-30.71%1 Year Performance-25.60% AVBP Stock Chart for Monday, September, 22, 2025 AVBP Chart by TradingView ArriVent BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/19/2025$18.58$17.65-5.01%$18.58$17.591.52 million shs$716.06 million09/18/2025$17.51$18.58+6.11%$18.63$17.64358,004 shs$753.79 million09/17/2025$18.20$17.51-3.79%$18.70$17.21311,028 shs$738.36 million09/16/2025$18.95$18.20-3.96%$19.20$18.02215,745 shs$738.37 million09/15/2025$19.71$18.95-3.86%$19.99$18.75268,018 shs$768.80 million09/12/2025$19.02$19.71+3.63%$19.78$18.93297,391 shs$799.64 million09/11/2025$18.87$19.02+0.79%$19.50$18.69490,718 shs$771.62 million09/10/2025$19.82$18.87-4.79%$19.66$18.35424,616 shs$765.56 million09/09/2025$20.21$19.82-1.93%$20.76$19.46261,246 shs$804.10 million09/08/2025$20.19$20.21+0.10%$20.99$19.86524,067 shs$819.90 million Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 09/05/2025$19.52$20.19+3.43%$20.45$19.31477,296 shs$819.09 million09/04/2025$19.24$19.52+1.46%$19.64$18.40182,673 shs$791.93 million09/03/2025$19.84$19.24-3.02%$20.63$19.11172,123 shs$780.57 million09/02/2025$19.12$19.84+3.77%$20.35$18.91346,343 shs$804.89 million09/01/2025$19.12$19.12$19.53$18.65225,185 shs$775.70 million08/29/2025$19.21$19.12-0.47%$19.53$18.65225,185 shs$775.70 million08/28/2025$19.21$19.21$19.58$19.09149,509 shs$779.35 million08/27/2025$19.59$19.21-1.94%$19.47$18.61273,090 shs$779.35 million08/26/2025$19.35$19.59+1.24%$19.75$19.35197,378 shs$794.77 million08/25/2025$20.11$19.35-3.78%$21.19$19.28184,648 shs$785.03 million08/22/2025$19.88$20.11+1.16%$20.86$19.94297,405 shs$815.86 million08/21/2025$19.27$19.88+3.17%$19.90$18.99105,678 shs$806.53 million Related Companies MorphoSys Stock Chart Ultragenyx Pharmaceutical Stock Chart Centessa Pharmaceuticals Stock Chart Xenon Pharmaceuticals Stock Chart CG Oncology Stock Chart NewAmsterdam Pharma Stock Chart Organon & Co. Stock Chart ImmunityBio Stock Chart Immunovant Stock Chart Viking Therapeutics Stock Chart Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVBP) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVBP Stock Alerts